Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptors, in a mouse model of Dravet syndrome.

导出 LinkOut

翻译打印收藏纠错

作者： Sachiko,Nakakubo ^[1] ; Yasuyoshi,Hiramatsu ^[1] ; Takeru,Goto ^[1] ; Syuhei,Kimura ^[1] ; Masashi,Narugami ^[1] ; Midori,Nakajima ^[1] ; Yuki,Ueda ^[1] ; Hideaki,Shiraishi ^[1] ; Atsushi,Manabe ^[1] ; Dishary,Sharmin ^[2] ; James M,Cook ^[2] ; Kiyoshi,Egawa ^[1]

作者单位： Department of Pediatrics, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan. ^[1] Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, United States. ^[2]

关键词 Dravet syndrome antiseizure anxiolytics mouse model positive allosteric modulator for α2/3 subunit containing GABA A receptor

DOI 10.3389/fphar.2023.1273633

PMID 37849734

发布时间 2023-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2023年14卷

1273633页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptors, in a mouse model of Dravet syndrome.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptors, in a mouse model of Dravet syndrome.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除